Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 127.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 127.0 | 77 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 135.0 | 81 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 143.0 | 55 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 124.5 | 58 | |
N2586 | IL-17A | 100 | ng/mL | 1 | M-CSF | 275.5 | 40 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 218.0 | 30 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 276.5 | 32 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 241.5 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 184.0 | 38 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | M-CSF | 203.0 | 59 | |
RA2159 | 1 | M-CSF | 131.0 | 45 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | M-CSF | 209.0 | 77 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | M-CSF | 113.0 | 69 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | M-CSF | 131.0 | 75 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 135.0 | 50 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | M-CSF | 130.0 | 77 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | M-CSF | 119.0 | 45 | ||||
N2586 | 1 | M-CSF | 201.0 | 59 | |||||||
N2586 | PD184352 | 0.1 | uM | 1 | M-CSF | 192.0 | 53 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 1 | M-CSF | 181.5 | 48 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | M-CSF | 181.0 | 50 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 199.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | M-CSF | 150.0 | 63 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | M-CSF | 140.0 | 57 |